Efficacy of Anti Ectera drop in Prevention of neonatal Jaundice

Investigation of the efficacy of Anti Ectera drop in Prevention of neonatal Jaundice

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201129049527N2

Enrollment

130

Registered

2021-03-17

Start date

2020-12-21

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal Hyperbilirubinaemia

Interventions

Intervention 1: Intervention group: Mothers (n = 65) are given Anti Ectera drops (made by Shahid Beheshti School of Pharmacy) and mothers give the drops to their babies every 8 hours for 3 weeks from

Eligibility

Sex/Gender

All

Age

1 Days to 2 Days

Inclusion criteria

Inclusion criteria: Parent’s consent to participate in the study Mothers be more than 18 years old and under 35 years old The mothers of the neonates without any an underlying disease The neonate's mother does not have high blood pressure or gestational diabetes Term newborn Apgar score>7 Neonate weighs less than 2.5 or more than 4 kg Neonate without congenital abnormalities

Exclusion criteria

Exclusion criteria: Diagnosis of G6PD in neonate Incidence of jaundice on the first day of birth Diagnosis of infection in neonate

Design outcomes

Primary

Measure	Time frame
Incidence and extent of jaundice in neonates. Timepoint: Before and after prescription of Anti-Ectera drops. Method of measurement: Laboratory test for bilirubin.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Manouchehrian

Kerman University of Medical Sciences

manouchehrian.m@iums.ac.ir+98 21 4432 8882

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026